Concepedia

Fatemeh Masrorpour

FM

Statistics

Publications

15

Citations

1.3K

H-Index

14

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Shandong First Medical University

Shandong Tumor Hospital

Nanobiotix (France)

Koç University

Fatemeh Masrorpour is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2012–2025

15

Publications

15

Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers, Jing Wang, Monique B. Nilsson et al. · Cancer Discovery · 2012 · 571 citations · Full text

, , +17

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed Younes et al. · Journal for ImmunoTherapy of Cancer · 2020 · 212 citations · Full text

, , +17

Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects

Yun Hu, Sébastien Paris, Hampartsoum B. Barsoumian et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 93 citations

, , +16

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

Robert J. Cardnell, Ying Feng, Seema Mukherjee et al. · PLoS ONE · 2016 · 87 citations · Full text

, , +17

Bone morphogenetic protein 7 promotes resistance to immunotherapy

María Angélica Cortez, Fatemeh Masrorpour, Cristina Ivan et al. · Nature Communications · 2020 · 59 citations · Full text

, , +17

1–5 of 15